NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyTransmission of Human Immunodeficiency Virus (HIV) In Semen (R01)
About This Grant
Purpose. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) through its Division of Kidney, Urologic and Hematologic Diseases (DKUHD) and the National Institute of Child Health and Human Development, Center for Population Research invite investigators to submit research grant applications that will increase the basic and clinical knowledge of the biology of HIV in semen. Direct exposure to semen of HIV seropositive men is a major route for transmission of HIV type I. This Funding Opportunity Announcement (FOA) focuses on studies that will elucidate the factors that determine HIV shedding in the male genital tract. This includes studies that elucidate the infectivity of HIV in semen fractions, the effect of antiretroviral therapy on HIV infectivity in semen fractions, the relationship between the immunobiology of the male genital tract and HIV replication and infectivity, and factors such as genital tract inflammation which influence HIV transmission through semen. Of particular interest are studies of the anatomic sites of virus infected cells and virus production in the male genital tract. The intent of this Funding opportunity is to encourage investigator-initiated research, to attract new investigators to the field, and to increase interdisciplinary research to enhance the scope and effectiveness of research in this area.
Grant Summary
Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01) is a National Institutes of Health grant providing funding that varies by award for municipality. Applications are accepted on a rolling basis. Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $0K
Rolling / Open
- 1Confirm your organization is eligible for Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01) from National Institutes of Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01): Frequently Asked Questions
Who is eligible for the Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01)?
Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01) is offered by National Institutes of Health and is generally open to municipality. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01) provide?
Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01) provides an amount that varies by award per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01) deadline?
Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01) accepts applications on a rolling or ongoing basis, so there is no single fixed deadline. Confirm current timing with the funder, National Institutes of Health, before you apply, and submit as early as possible because rolling programs can close once funds are committed.
How do you apply for the Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01)?
To apply for Transmission of Human Immunodeficiency Virus (HIV) In Semen (R01), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.